Company news: Sanofi, Haymarket

Share this article:
Sanofi named Paul Chew to replace Jean-Pierre Lehner as SVP and Chief Medical Officer. Lehner, is leaving his post December 31, the company announced Monday, and has been with Sanofi for more than 20 years, having taken on his current role three years ago. Chew is also a Sanofi vet, and as of January 1 will become head of global affairs as well as chief medical officer. Chew, a cardiologist, will be ferrying between offices in Bridgewater, NJ, and Paris, France. He was named SVP, chief medical officer/chief scientific officer, US, in 2009, and served as president, US R&D and VP therapeutic department head, metabolism, diabetes and thrombosis, in which role he oversaw Lovenox, Lantus and the therapeutic development portfolio from 2007 to 2009.

The Clinical Advisor, an MM&M sister company under Haymarket Media, has launched a free app for nurse practitioners and physician assistants. Users will be able to use the app to read the print journal, take Derm Dx quizzes, read about drug approvals and recalls, and tap into CME courses from the myCME education library. US Biomedical Information Systems helped develop the Apple IOS app; the Android version will be available later this year.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.